National Institute of Diabetes and Digestive and Kidney Diseases Notice of Closed Meeting, 78373 [2013-30746]
Download as PDF
<![CDATA[
78373
Federal Register / Vol. 78, No. 248 / Thursday, December 26, 2013 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Substance Abuse and Mental Health
Services Administration
National Institute of Diabetes and
Digestive and Kidney Diseases Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR–12–265Ancillary Studies to Major Ongoing Clinical
Studies in NIDDK (RO1): CKD and Diabetic
Nephropathy.
Date: February 20, 2014.
Time: 4:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
Dea, NIDDK, National Institutes Of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: December 19, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–30746 Filed 12–24–13; 8:45 am]
BILLING CODE 4140–01–P
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: SAMHSA Recovery
Measurement Pilot Study—NEW
The Substance Abuse and Mental
Health Services Administration
(SAMHSA), Center for Behavioral
Health Statistics and Quality (CBHSQ)
is proposing a pilot test of its Recovery
Measure. As part of its strategic
initiative to support recovery from
mental health and substance use
disorders, SAMHSA has been working
to develop a standard measure of
recovery that can be used as part of its
grantee performance reporting activities.
This project will assess the usability
and psychometric properties of the
proposed tool among a voluntary group
of 2–3 SAMHSA grantees. SAMHSA has
developed a short 20-item instrument
that has been designed to capture all
four of SAMHSA’s proposed
dimensions of recovery—health, home,
purpose, and community. This measure
is comprised of questions from the
World Health Organization’s Quality of
Life tool (WHO QOL 8) and SAMHSA’s
existing set of Government Performance
and Results Act (GPRA) measures. Data
will be collected at two time points—at
client intake and at six-months postintake. These are two points in time
during which SAMHSA grantees
routinely collect data on the individuals
participating in their programs.
Approval of these items by the Office
of Management and Budget (OMB) will
allow SAMHSA to further refine the
Recovery Measure developed for this
project. It will also help determine
whether the Recovery Measure is added
to SAMHSA’s set of required
performance measurement tools
designed to aid in tracking recovery
among clients receiving services from
the Agency’s funded programs.
Based on current funding and
planned fiscal year 2014 notice of
funding announcements the following
SAMHSA grantee programs will be
selected to participate in this pilot
study: Behavioral Health Treatment
Court Collaborative (BHTCC);
Cooperative Agreements to Benefit
Homeless Individuals (CABHI); and the
Primary and Behavioral Health Care
Integration (PBHCI). Data collected will
be used by individuals at three different
levels: the SAMHSA administrator and
staff, the Center administrators and
government project officers, and
grantees.
The total estimated respondent
burden is 60 hours for the period from
September 2014 through March 2015.
Table 1 below indicates the annualized
respondent burden estimate.
TABLE 1—ANNUALIZED RESPONDENT BURDEN HOURS, 2014–2015
emcdonald on DSK67QTVN1PROD with NOTICES
Estimated annual response burden
Number
of
respondents
Type of grantees
Intake:
Behavioral Health Treatment Court Collaborative (BHTCC) ....................
Cooperative Agreements to Benefit Homeless Individuals (CABHI) .......
Primary and Behavioral Health Care Integration (PBHCI) .......................
6-Month Follow-up:
VerDate Mar<15>2010
18:06 Dec 24, 2013
Jkt 232001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Responses
per
respondent
100
50
150
E:\FR\FM\26DEN1.SGM
Average hours
per response
1
1
1
26DEN1
0.10
0.10
0.10
Total burden
hours
10
5
15
]]>Agencies
[Federal Register Volume 78, Number 248 (Thursday, December 26, 2013)]
[Notices]
[Page 78373]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-30746]
[[Page 78373]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; PAR-12-265-Ancillary
Studies to Major Ongoing Clinical Studies in NIDDK (RO1): CKD and
Diabetic Nephropathy.
Date: February 20, 2014.
Time: 4:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Najma Begum, Ph.D., Scientific Review Officer,
Review Branch, Dea, NIDDK, National Institutes Of Health, Room 749,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8894,
begumn@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: December 19, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-30746 Filed 12-24-13; 8:45 am]
BILLING CODE 4140-01-P
